Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

A multi-discipline approach to personalised medicine

Prof Vincenzo Valentini – President of ESTRO; Prof Peter Naredi – ESSO, Former President; Prof Paolo Casali – ESMO, Executive Board Member
A multi-discipline approach to personalised medicine ( Prof Vincenzo Valentini – President of ESTRO; Prof Peter Naredi – ESSO, Former President; Prof Paolo Casali – ESMO, Executive Board Member )
22 Oct 2012

Challenges to the development of personalised medicine

Prof Alexander Eggermont – President of the European Academy of Cancer Sciences; Prof Franҫoise Meunier – Director General, EORTC
Challenges to the development of personalised medicine ( Prof Alexander Eggermont – President of the European Academy of Cancer Sciences; Prof Franҫoise Meunier – Director General, EORTC )
22 Oct 2012

Development of oncology policy

Prof Jose Mariano Gago – ECCO Political Advisor
Development of oncology policy ( Prof Jose Mariano Gago – ECCO Political Advisor )
22 Oct 2012

Progress of personalised oncology treatment

Prof Martine Piccart – President-Elect of ECCO
Progress of personalised oncology treatment ( Prof Martine Piccart – President-Elect of ECCO )
22 Oct 2012

The value of cancer care and society

Prof Richard Sullivan – Kings College London, UK
The value of cancer care and society ( Prof Richard Sullivan – Kings College London, UK )
23 Jul 2012

Palliative care and affordable morphine

Prof Anne Merriman – Hospice Africa, Uganda
Palliative care and affordable morphine ( Prof Anne Merriman – Hospice Africa, Uganda )
20 Jul 2012

Translational and tailored, but can we afford it?

Prof Gordon McVie - European Institute of Oncology and ecancer
Translational and tailored, but can we afford it? ( Prof Gordon McVie - European Institute of Oncology and ecancer )
17 Jul 2012

Translational and tailored, but can we afford it?

Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden
Translational and tailored, but can we afford it? ( Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden )
17 Jul 2012

Cost efficiency of targeted therapy

Dr Maria Grazia Daidone - Foundazione IRCCS Istituto Nazionale dei Tumori, Italy
Cost efficiency of targeted therapy ( Dr Maria Grazia Daidone - Foundazione IRCCS Istituto Nazionale dei Tumori, Italy )
17 Jul 2012

Society and money - the cancer conundrum

Prof Richard Sullivan – Kings College, London, UK
Society and money - the cancer conundrum ( Prof Richard Sullivan – Kings College, London, UK )
17 Jul 2012

Translating cancer research to personalised treatment: Can it work?

Prof Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Translating cancer research to personalised treatment: Can it work? ( Prof Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
17 Jul 2012

Drugging the cancer genome: opportunities and challenges

Prof Paul Workman - Institute of Cancer Research, UK
Drugging the cancer genome: opportunities and challenges ( Prof Paul Workman - Institute of Cancer Research, UK )
16 Jul 2012